MiniMed Group Inc. Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? MiniMed Group Inc. Common Stock trades at $19.71 (market cap $5.57B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 4.5× MiniMed Group Inc. Common Stock's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while MiniMed Group Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 1 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| MMED | RPRX | |
|---|---|---|
Market Cap | $5.57B | $25.27B |
Volume | 23,336,073 | 3,671,183 |
Sector | Health | Health |
52-Week High | $23.84 | $63.96 |
52-Week Low | $10.80 | $35.44 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.37B | $32.50B |
Dividend Yield | — | 1.66% |
Trailing returns across standard periods
Latest headlines on both assets
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →